Macrogenics (MGNX) Total Non-Current Liabilities (2012 - 2026)

Macrogenics (MGNX) has reported Total Non-Current Liabilities for 12 consecutive years, with $195.9 million the latest figure, recorded in Q1 2026.

• In Q1 2026, Total Non-Current Liabilities rose 36.57% year-over-year to $195.9 million; the TTM figure through Mar 2026 stood at $195.9 million (up 36.57% YoY), while the FY2025 annual figure was $200.2 million, up 39.39% from the prior year.
• Total Non-Current Liabilities retreated to $195.9 million in Q1 2026 per MGNX's latest filing, from $200.2 million in the prior quarter.
• Across five years, Total Non-Current Liabilities topped out at $234.0 million in Q1 2023 and bottomed at $72.1 million in Q3 2022.
• Historically, Total Non-Current Liabilities has averaged $150.0 million across 5 years, with a median of $143.6 million in 2024.
• Annual changes were most pronounced in 2023 — Total Non-Current Liabilities jumped 151.66% — and 2024, when it slumped 39.36%.
• Macrogenics' Total Non-Current Liabilities stood at $138.2 million in 2022, then climbed by 5.32% to $145.5 million in 2023, then dropped by 1.32% to $143.6 million in 2024, then jumped by 39.39% to $200.2 million in 2025, then decreased by 2.13% to $195.9 million in 2026.
• Business Quant data shows MGNX's Total Non-Current Liabilities at $195.9 million in Q1 2026, $200.2 million in Q4 2025, and $202.4 million in Q3 2025.